<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To report a 31-year-old healthy patient with <z:chebi fb="46" ids="15035">retinal</z:chebi> venous occlusion in his left eye attributable to primary <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The patient was examined clinically </plain></SENT>
<SENT sid="2" pm="."><plain>Multiple serologic and clinical investigations were performed to determine the causative disease </plain></SENT>
<SENT sid="3" pm="."><plain>He was closely followed up for more than 3 years </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> in our patient was indicated by a kaolin clotting time index of 27 (<z:mpath ids='MPATH_458'>normal</z:mpath>, &lt;17) and confirmed by the demonstration of IgG antibodies against <z:chebi fb="1" ids="16247">phospholipids</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>After long-term oral <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> treatment for 2 years, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> levels returned to <z:mpath ids='MPATH_458'>normal</z:mpath>, and therapy was stopped </plain></SENT>
<SENT sid="6" pm="."><plain>No further thrombotic event occurred during follow-up </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: In <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusions</z:e> of unexplained origin, <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> may play an important role in the pathogenesis </plain></SENT>
<SENT sid="8" pm="."><plain>Detecting these antibodies in the serum of patients with <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> helps determine the appropriate treatment with long-term oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> </plain></SENT>
</text></document>